Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8264106 | Experimental Gerontology | 2014 | 7 Pages |
Abstract
In summary, the developed population model can be used to assess the pharmacokinetic parameters of CPX in the elderly patients and to select on the basis of these parameters and MIC values an optimal dosage regimen of this drug.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Agnieszka Cios, Elżbieta Wyska, Joanna Szymura-Oleksiak, Tomasz Grodzicki,